Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)
China
· Delayed Price · Currency is CNY 20.18
+0.22 (1.10%)
Mar 10, 2026, 11:29 AM CST
SHA:605266 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,957 | 3,614 | 7,654 | 7,940 | 5,324 | 5,889 | Upgrade
|
| Market Cap Growth | -16.47% | -52.78% | -3.61% | 49.15% | -9.61% | - | Upgrade
|
| Enterprise Value | 6,646 | 7,009 | 9,792 | 10,142 | 5,254 | 5,491 | Upgrade
|
| Last Close Price | 19.96 | 21.96 | 45.84 | 46.71 | 33.45 | 36.55 | Upgrade
|
| PE Ratio | 24.05 | 28.21 | 18.47 | 21.21 | 17.71 | 23.45 | Upgrade
|
| Forward PE | - | 20.53 | 20.53 | 21.41 | 22.46 | 19.39 | Upgrade
|
| PS Ratio | 0.33 | 0.39 | 0.84 | 1.06 | 1.02 | 1.32 | Upgrade
|
| PB Ratio | 1.13 | 1.30 | 2.69 | 3.09 | 2.81 | 3.46 | Upgrade
|
| P/TBV Ratio | 31.04 | 14.13 | 20.92 | 31.57 | 3.67 | 3.62 | Upgrade
|
| P/FCF Ratio | 4.51 | 14.99 | 10.57 | 19.37 | 14.83 | 32.08 | Upgrade
|
| P/OCF Ratio | 3.57 | 7.10 | 7.47 | 6.67 | 7.15 | 18.60 | Upgrade
|
| EV/Sales Ratio | 0.73 | 0.76 | 1.08 | 1.35 | 1.00 | 1.23 | Upgrade
|
| EV/EBITDA Ratio | 5.81 | 17.80 | 13.84 | 16.92 | 12.58 | 17.22 | Upgrade
|
| EV/EBIT Ratio | 20.74 | 21.59 | 15.31 | 18.55 | 13.58 | 18.70 | Upgrade
|
| EV/FCF Ratio | 10.15 | 29.08 | 13.52 | 24.74 | 14.64 | 29.91 | Upgrade
|
| Debt / Equity Ratio | 1.71 | 1.56 | 1.30 | 1.14 | 0.68 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 3.91 | 3.79 | 2.66 | 2.54 | 1.48 | 0.33 | Upgrade
|
| Debt / FCF Ratio | 6.83 | 18.01 | 5.10 | 7.16 | 3.57 | 0.57 | Upgrade
|
| Net Debt / Equity Ratio | 1.41 | 1.26 | 0.98 | 0.78 | 0.16 | -0.89 | Upgrade
|
| Net Debt / EBITDA Ratio | 9.45 | 8.93 | 3.94 | 3.33 | 0.72 | -4.76 | Upgrade
|
| Net Debt / FCF Ratio | 5.63 | 14.59 | 3.85 | 4.88 | 0.83 | -8.26 | Upgrade
|
| Asset Turnover | 0.89 | 0.90 | 0.93 | 1.01 | 1.21 | 1.64 | Upgrade
|
| Inventory Turnover | 2.10 | 2.18 | 2.58 | 2.94 | 3.64 | 4.44 | Upgrade
|
| Quick Ratio | 0.30 | 0.24 | 0.29 | 0.37 | 0.52 | 1.06 | Upgrade
|
| Current Ratio | 0.81 | 0.86 | 0.81 | 0.93 | 1.03 | 1.63 | Upgrade
|
| Return on Equity (ROE) | 4.84% | 4.55% | 15.32% | 16.79% | 16.65% | 21.88% | Upgrade
|
| Return on Assets (ROA) | 1.96% | 1.97% | 4.08% | 4.60% | 5.57% | 6.71% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.01% | 4.12% | 9.95% | 13.74% | 27.19% | 127.99% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.00% | 6.30% | 12.60% | 10.10% | 13.80% | 16.80% | Upgrade
|
| Earnings Yield | 4.33% | 3.55% | 5.42% | 4.71% | 5.64% | 4.26% | Upgrade
|
| FCF Yield | 22.15% | 6.67% | 9.46% | 5.16% | 6.74% | 3.12% | Upgrade
|
| Dividend Yield | 5.47% | 5.01% | 2.34% | 2.00% | 2.32% | 2.39% | Upgrade
|
| Payout Ratio | 191.69% | 188.76% | 49.45% | 41.42% | 41.27% | 1.78% | Upgrade
|
| Buyback Yield / Dilution | 0.55% | 0.17% | -1.91% | -8.55% | -21.58% | -9.73% | Upgrade
|
| Total Shareholder Return | 6.02% | 5.18% | 0.43% | -6.55% | -19.26% | -7.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.